SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Syndeio CEO Derek Small,
Funding
Karuna, Naurex Alumni Launch New Biotech to Modulate Synaptic Plasticity for Neuro Diseases
With $90 million to start, Syndeio has a lead asset in Phase II clinical trials for major depressive disorder, with plans to soon launch a biomarker trial in Alzheimer’s disease.
May 27, 2025
 · 
3 min read
 · 
Heather McKenzie
TV host Dr. Mehmet Oz speaking at a Senate hearing
Drug pricing
Trump Taps Oz To Lead Drug Pricing Negotiations as Customs Warns Against Import Violations
According to President Trump, CMS Administrator Mehmet Oz is a “tough hombre” who can bring down drug costs “like a rock.”
May 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Rare diseases
Prothena Looks at Business Options as Phase III AL Amyloidosis Trial Fails
Prothena has already discontinued the development of birtamimab, and anticipates further spending cuts, including workforce reduction.
May 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
mRNA Helped Quell COVID-19 but COVID-19 ‘Maimed’ mRNA
Vocal skeptics of COVID-19 vaccinations gave mRNA a bad name and government funding for mRNA research is now being cut. On the flip side, at least one CEO said the pandemic also provided “elevated acceleration” for the field, which also holds promise in therapeutics for cancer and rare diseases.
May 27, 2025
 · 
6 min read
 · 
Heather McKenzie
Coronavirus on stock market crisis business motion Financial Stock market crisis falling down in Wuhan Covid-19. Coronavirus financial outbreak losses, down Graph in front of Coronavirus Concept
COVID-19
4 Biotechs Caught Up in Uncertain COVID-19 Vaccine Landscape
As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future of vaccine development in the U.S. faces growing challenges, including waning funding and regulatory changes, that threaten next-gen COVID-19 vaccine candidates and pandemic preparedness more broadly.
May 27, 2025
 · 
7 min read
 · 
Ben Hargreaves
Chicago, Illinois, USA on Lake Michigan at dawn.
Cancer
Practice-Changing Data, Innovative Modalities and China in Focus at #ASCO25
Beginning this week in Chicago, the American Association for Cancer Research’s annual conference will feature presentations that could have far-reaching implications for breast and blood cancers and more.
May 27, 2025
 · 
7 min read
 · 
Tristan Manalac
USA Flag formed by COVID-19 vaccine and blood test vials, 2019 pandemic United States of America, concept patriotic fighting coronavirus response, 3d illustration
FDA
‘Make American Healthy Again’ Report Takes Aim at Pharma Lobbying, GLP-1s and Vaccines
The report takes from HHS Secretary Robert F. Kennedy Jr’s playbook, calling out rising autism rates, the vaccine schedule and over medication of children as reasons for chronic diseases.
May 23, 2025
 · 
4 min read
 · 
Annalee Armstrong
Robert F Kennedy Jr speaking at the White House
Government
Court Halts HHS’ Reduction and Layoff Plans, Arguing a Lack of Authority
In an opinion issued late Thursday night, U.S. District Judge Susan Illston wrote that the president and department agency heads do not have the authority to reorganize the government without Congress’ input.
May 23, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
A contemporary artistic collage featuring a hand holding a trophy. The concept of victory and achievement.
Cancer
Merus’ Bispecific Shows ‘Best in Disease’ Profile in Head-and-Neck Cancer Ahead of ASCO
Analysts were effusive about Merus’ new HNSCC data, writing that petosemtamab could “become the standard of care” in the first-line setting for this indication.
May 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS